Tag Archives: BIO International Convention

2012 Fall Event Preview

agenda

The 2012 BIO International Convention, the global event for biotechnology, held at the Boston Convention & Exhibition Center in Boston, Mass., wrapped this June. The event hosted a record 25,291 partnering meetings and highlighted a broad array of top-level speakers addressing critical global challenges and the top issues in biotechnology. Hosted by the Biotechnology Industry Organization (BIO), the event drew 16,505 industry leaders from 49 states and 65 countries. See what BIO President and CEO Jim Greenwood Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Senator John Kerry and the 2012 BIO International Convention

kerry-btn

One of our scheduled keynote speakers at the 2012 BIO International Convention in Boston was Senator John Kerry of Massachusetts. Unfortunately the Senator was unable to join us as planned when his duties kept him in Washington, DC for votes on important legislation. Senator Kerry has been a strong supporter of biomedical innovation. During the health care reform debate, Senator Kerry strongly supported and fought for a 12-year data exclusivity period for innovative biomedicines and Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , ,

Vaccines Beyond 2012

polio-vaccine

Each year, approximately 1.7 million children die from a vaccine-preventable disease, and the vast majority of these deaths occur in developing countries. This BIO 2012 session, moderated by Peg Willingham of the United Nations Foundation, addressed various ways industry can help increase access to life-saving vaccines for children and adults in resource-poor countries. The thoughts of a few of the speakers on the panel for this session are summarized below. The panelists suggested that for Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Telling the Biotech Story at the BIO International Convention

convention-ribbon

The global event for biotechnology wrapped up last week at the Boston Convention & Exhibition Center in Boston, Mass. The event was a huge success, with a record 25,291 partnering meetings and hundreds of high-level speakers addressing critical global challenges and opportunities. More than 16,500 industry leaders from 49 states and 65 countries attended, yet again earning the title as the largest biotechnology event in the world. People are always asking for my perspective on our Convention, Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , , ,

Implementing the WHO PIP Framework – Industry’s Role & Outlook

syringe

In May 2011, the World Health Organization (WHO) adopted the Pandemic Influenza Preparedness (PIP) Framework after nearly five years of contentious negotiations. As noted by Anne Huvos, WHO Secretariat, the two objectives of the PIP Framework are: (1) to improve sharing of influenza viruses with human pandemic potential; and (2) to achieve more predictable, efficient, and equitable access to benefits, such as vaccines and antiviral medicines, during future pandemics. The subject of a session at Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,